Brind.

Fiona Marshall has been appointed President of Biomedical Research at Novartis.

1 report, 1 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Fiona Marshall

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
Fiona Marshall
researcher ORCID ID = 0000-0002-1512-4271

Nothing else this week.

Related events

Avidity Biosciences, a San Diego-based company, announced a partnership with Eli Lilly and is also facing acquisition interest from Novartis.Jun 7
Novartis CEO joined Anthropic's board.Wed 16:49

Coverage

Newest first; wire copies grouped

Jun 26miragenews.com